Abstract
During development, motor neurons originating in the brainstem and spinal cord form elaborate synapses with skeletal muscle fibers1. These neurons release acetylcholine, which binds to nicotinic acetylcholine receptors on the muscle, initiating contraction. Two types of acetylcholine receptors are present in developing muscle cells, and their differential expression serves as a hallmark of neuromuscular synapse maturation2–4. The structural principles underlying the switch from fetal to adult muscle receptors are unknown. Here, we present high resolution structures of both the fetal and adult muscle nicotinic acetylcholine receptors, isolated from bovine skeletal muscle in developmental transition. These structures, obtained in the absence and presence of acetylcholine, provide a structural context for understanding how the fetal versus adult receptor isoforms are tuned for synapse development versus the all or none signaling required for high fidelity skeletal muscle contraction. We find that ACh affinity differences are driven by binding site access, channel conductance is tuned by widespread surface electrostatics, and open duration changes result from intrasubunit interactions and structural flexibility. The structures further reveal pathogenic mechanisms underlying congenital myasthenic syndromes.
Skeletal muscle contraction is initiated by the release of the neurotransmitter acetylcholine (ACh) from motor neurons onto ACh receptors (AChR) at specialized synapses. Early in development, AChRs are diffusely prepatterned across the surface of muscle cells5,6. Motor neurons spontaneously release small amounts of ACh7,8, causing electrical activity in the muscle and repressing receptor expression in extrasynaptic nuclei. Innervation induces receptor accumulation at nerve-muscle contact sites, and formation of neuromuscular junctions (NMJ)9,10 around the time of birth. In adults, ACh binding to the postsynaptic receptor causes ion channel opening, cation permeation, and local depolarization of the muscle fiber, triggering strong muscle contraction11.
Muscle AChRs undergo a developmental switch in subunit composition at the time of motor neuron innervation (Fig. 1a, b)2,5,12. Fetal muscle receptors have a high sensitivity to ACh13–15, lower conductance3,16,17 and, longer open channel duration16. These properties enable muscle activity from spontaneously released neurotransmitter, which is essential for the differentiation of the NMJ and ontogenetic death of motor neurons7,18,19. Substitution of the fetal AChR with the adult isoform leads to abnormal NMJ development7,20, because of the adult isoform’s low sensitivity to ACh13,14, higher conductance17, and briefer openings16. However, these distinct properties render adult receptors ideally tailored for robust and reproducible high-frequency neuromuscular transmission at mature synapses21, where ACh reaches millimolar concentrations22.
Figure 1: NMJ and AChR structures in fetal and adult stages of development.

a, b, Cartoons of immature (a) and mature (b) NMJ synapses illustrating differences in biophysical properties of fetal and adult AChRs, including ACh sensitivity and ion conductance. c, d, Cryo-EM maps of fetal AChRs bound to neurotoxin in a resting-like state (c) and ACh in a desensitized state (d), top and side views. e, f, Cryo-EM maps of adult AChRs bound to neurotoxin in a resting-like state (e) and ACh in a desensitized state (f), top and side views. Unique glycosylation for γ subunit (γN52-glycan) and ε subunit (εN86-glycan) assignment is indicated as cyan colored densities.
Muscle AChRs are composed of five homologous subunits arranged in a ring to form a cation-selective ion channel through the cell membrane23,24. Fetal receptors contain two α1 subunits, and one each of β1, γ, and δ. In adults, the γ subunit is replaced by ε2,25, in which most of the mutations causing congenital myasthenic syndromes are found26–28. To date, there has been no structural information for a bona fide muscle AChR. Recent structures of the Torpedo electric organ AChR24,29,30, homologous to the mammalian fetal muscle receptor, are the current best model, but fail to address mature receptor physiology, and congenital myasthenia. Here we present structures of native fetal and adult muscle AChRs, revealing how the developmental switch alters channel biophysics and pharmacology to enable NMJ maturation. These findings further illuminate how mutations in the adult receptor cause myasthenic syndromes.
Tissue in developmental transition contains both receptor isoforms
While the density of AChRs at the mature NMJ is high, their overall amount in skeletal muscle is only ~6 μg per 100 g of tissue31. We used fetal bovine skeletal muscle for AChR isolation, as bovine muscle is readily obtainable in quantity, and fetal tissue contains higher receptor levels than adult32. We engineered a 3-finger peptide neurotoxin for affinity purification of the receptor on a kilogram tissue scale (see Methods). Briefly, skeletal muscle was homogenized and fractionated by centrifugation. Membranes were solubilized in detergent with phospholipids and cholesterol added throughout purification to stabilize the receptor (Extended Data Fig. 1a). The approach was iteratively optimized and the receptor was tracked using fluorescently-labeled α-bungarotoxin (Extended Data Fig. 1c, d, e). Final yields were ~30 μg of AChR per kg muscle; this purified receptor was applied to electron microscopy grids, frozen, and imaged (Extended Data Figs. 1, 2, 4).
To our surprise, we identified both fetal and adult muscle receptors from this tissue, by mass spectrometry (Extended Data Fig. 1i), and in high-resolution cryo-EM 3D-reconstructions (Fig. 1, Extended Data Fig. 3). Precocial animals that can walk on the day they are born likely complete the developmental switch in subunit composition, to form mature NMJs, well before birth3. Accordingly, even the early-stage fetal skeletal muscle contains both fetal and adult AChRs, serendipitously revealing structures of both from the same cryo-EM sample.
Native receptor structures in different functional states
We refined the toxin-bound fetal and adult receptor cryo-EM maps to 2.1 Å overall resolution (Fig. 1c, e, Extended Data Fig. 2, 5, Video 1). These structures serve as references for a non-conducting, resting-like state of the receptor24,33,34. To probe neurotransmitter recognition and ACh-induced conformational changes, we displaced toxin with ACh (Extended Data Fig. 1b, h). This competition experiment resulted in structures of ACh-bound fetal and adult receptors, both at 2.5 Å resolution (Fig. 1d, f, Extended Data Fig. 4, 5, Video 1). At equilibrium, saturating ACh results in receptor desensitization; these ACh-bound structures represent non-conducting desensitized states. The high quality of the density maps enabled de novo model building of most of the receptor as well as toxin, ACh, and lipids. The five receptor subunits are arranged as αγ-γ-αδ-δ-β (fetal) and αε-ε-αδ-δ-β (adult) around the channel axis (Fig. 1c–f, Extended Data Fig. 6a–e). Each subunit has a typical Cys-loop receptor ECD fold of mostly β strands and a transmembrane domain (TMD) containing four helices, M1-M4. The intracellular domain (ICD) includes an amphipathic post-M3 helix (MX) and an MA helix that is continuous with M4 (Extended Data Fig. 6e). In contrast to the short helical C-terminus in α subunits, the γ, ε, δ, and β subunits have extended C-termini stabilized through interactions with their respective ECDs (Extended Data Fig. 6k–o). In addition to a common, large N-linked glycan emanating from a conserved asparagine in the Cys-loop of all muscle receptor subunits, the γ, ε, and δ subunits each have a unique glycosylation site (Extended Data Fig. 3, 6f–j). The combination of distinctive C-termini and N-glycosylation patterns allowed for the successful 3D classification and proper subunit identification during cryo-EM data processing (Extended Data Fig. 2–4).
Neurotransmitter sensitivity
The fetal AChR has a 30-fold higher affinity for ACh compared to the adult isoform13, which enables detection of the sparse ACh released during the earliest stages of NMJ development7,35. Comparison of the fetal and adult receptor structures bound to ACh reveals differences underlying this sensitivity, which stem from the unique αγ and αε interfaces (Fig. 2a, b). The quaternary ammonium group of ACh is tightly encapsulated by five conserved aromatic core residues from the α (αY113, αW169, αY210, αY218) and γ/ε (γW77/εW75) subunits (Fig. 2c, d). The ACh acetyl group is positioned to form a hydrogen bond with a water molecule coordinated by the main-chain atoms of γN129 on β5 and γL141 on the β6 strand (equivalent to εN127 and εL139) (Fig. 2c, d). In addition, γL141/εL139 are close to the aromatic core and should contribute to stabilization of ACh. Notably, these direct interactions are conserved between the fetal αγ and adult αε ACh sites, suggesting other factors must tune ACh affinity13–15.
Figure 2: Structural basis of ACh sensitivity.

a, b, Cryo-EM densities highlight the fetal αγ (a) and adult αε (b) interfaces for ACh binding; top views. The ACh density in each interface is shown in the upper-left corners. c, d, Cartoon structures of αγ (c) and αε (d) ACh binding pockets. ACh molecules are shown as yellow sticks. Interacting protein residues are shown as sticks and the interacting water molecules are shown as cyan spheres. e, f, Surface representations of αγ and αε interfaces reveal different compactness of ACh binding pockets. The accessible pocket volume is 91.8 Å3 in the fetal αγ interface, and 201.2 Å3 in the adult αε interface; also see Extended Data Figure 7e and 7f.
The structures reveal two striking features that differ between the αγ and αε interfaces to modulate ACh affinity. First, the ACh binding pocket in the αγ interface is more compact than in the αε interface, where the ACh acetyl group is solvent exposed (Fig. 2e, f). This difference in solvent access leads to slower ACh dissociation from the αγ site than from the αε binding site, consistent with predictions from simulations14,15 (Extended Data Fig. 7e, f). The compact αγ site results at least in part from two bulky substitutions, γY139/εS137 and γE79/εG77 (Fig. 2c, d). γY139 provides a hydrophobic cover, locking ACh in a more extensive aromatic box, and interacts with γE79 to occlude one side of the pocket (Fig. 2c). Second, the ACh sites differ in structural stability. The αγ interface harbors two additional interactions compared to the αε interface. One is an unpredicted disulfide bond between γC137 and γC83 (Extended Data Fig. 7a). Sequence comparisons suggest this clearly resolved disulfide is conserved in mammals, while it is absent in the Torpedo receptor (Extended Data Fig. 7c). This disulfide covalently links the β6 and β2 strands, both of which directly interact with ACh. Earlier simulations support the relative flexibility of the region being a determinant of fetal versus adult AChR sensitivities to neurotransmitter13. A final stabilizing element is a hydrogen bond interaction between the main-chain of αN115 and γN75 just adjacent to two core aromatic residues, αY113 and γW77 (Extended Data Fig. 7a, b). This interaction further stabilizes the aromatic box of the αγ ACh site and is absent in the αε site due to a substitution at εS73 (Extended Data Fig. 7d). These two distinguishing interactions endow the αγ interface with greater structural stability, explaining how the αγ site is better organized and less dynamic than αε14. Together, we conclude that the higher ACh sensitivity of the fetal receptor stems from the unique αγ interface being both more compact and more rigid than the αε interface of adult receptor.
Conductance difference
In a mature muscle cell at rest, the membrane potential is maintained near −85 mV. AChR opening results in non-selective cation permeation; at the strongly polarized potential, conductance is dominated by an influx of Na+ ions as well as Ca2+ 36. The adult receptor has a 50% higher single channel conductance than the fetal receptor (~60 pS vs. ~40 pS in bovine muscle3) and a higher relative Ca2+ permeability37,38. Comparisons of the fetal and adult AChR structures explain these distinctions underlying proper functioning of the adult NMJ. Negatively charged residues in the ion permeation pathway, including the polar ECD and ICD linings, and the largely hydrophobic TMD pore, are expected to be major determinants of channel conductance17,39,40 (Fig. 3a). Indeed, the adult receptor possesses a much more strongly electronegative surface through both the ECD channel vestibule and the ICD fenestrations compared to the fetal receptor (Fig. 3b–e). Lining the ECD vestibule, ε has four anionic residues that are either neutral or hydrophobic in γ (Extended Data Fig. 7g, i). The more negatively charged surface in the ε ECD vestibule would concentrate permeant cations41. The ε ICD also contains four anionic substitutions, specifically in the MA helix that frames intracellular portals where ions exit (Fig. 3d, e, Extended Data Fig. 7h, j). We found that neutralizing these four charges in the ε ICD decreased the single-channel conductance of the adult muscle receptor by ~20% (Fig. 3i, j), consistent with an observation in the α3β4 ganglionic AChR42. Interestingly, the γ ICD contains four positively charged substitutions (Extended Data Fig. 7k–m), similar to the 5-HT3A receptor, which has an unusually low single-channel conductance (Extended Data Fig. 7n)43.
Figure 3: Electrostatics endow the adult receptor with high conductance.

a, Side view of adult receptor with β subunit removed shows the ion permeation pathway (yellow dashed lines with arrows) that determines channel conductance. b–e, Electrostatic potential of ECD (b, c) and ICD (d, e) inner surfaces of fetal and adult receptors reveal different charge properties. Red, negative; blue, positive. f, Sequence alignment of γ and ε subunits. g, Superposition of the pore regions of fetal and adult structures reveals the K/Q at M2 20′ influences cation flux. h, Structural comparison reveals the residue differences on M2 helices. γV18′ and εI18′ insert into a pocket surrounded by hydrophobic residues. Corresponding residues in g and h are shown as sticks. i, Representative single-channel recordings from adult wild type and εE/K mutant (εD436K/εE438K/εE442K/εE443K) at different voltages. O, open; C, closed. j, Single channel conductance statistics for wild type (n = 5 independent cells, 53.28 ± 1.52 pS) and εE/K mutant (n = 7, 42.27 ± 2.14 pS). Error bars denote the mean ± s.e.m.; Welch’s t-test was used.
The M2 helices from each subunit line the TMD pore. These segments, given prime numbers counting from bottom to top of M2, differ at only four positions between ε and γ (Fig. 3f). γK20′ at the top of the pore orients inward in both the resting-like and desensitized states (Fig. 3g), ideally positioned to tune cation flux. Acidic substitutions here enhance both overall conductance and relative Ca2+ permeability in multiple cationic Cys-loop receptors39,44,45. This repelling, positive charge in γ is neutralized in ε (εQ20′) (Fig. 3g). In the intracellular mouth of the pore, γK268 is replaced by εQ267 (Fig. 3f). Basic residues at these two positions are structurally unfavorable for cation flux, and dampen muscle receptor conductance17. Both γV18′/εI18′ and γA4′/εS4′ on M2 orient away from the pore axis; how these substitutions affect channel function is more speculative. The 18′ substitution could enhance the hydrophobic interactions with surrounding residues (Fig. 3h) and stabilize the M2 helix conformation during channel opening, which could in turn increase conductance of the adult receptor. The change at 4′ in combination with two K-Q replacements is known to regulate conductance of both muscle receptor isoforms17. Together, structural and functional data define specific charge reversals and neutralizations along the entire ECD-TMD-ICD permeation pathway that result in the higher conductance of the adult muscle AChR.
State transition reveals an extensive gate
Comparison of the adult resting-like and desensitized state structures reveals asymmetric conformational changes beginning in the ACh binding sites and extending to the channel pore (Fig. 4a–d, Extended Data Video 2). The conformational transitions in the M2 helices result in overlapping gates blocking ion flux in the two observed non-conducting states. In the resting-like state, two hydrophobic constrictions connected by three rings of hydrophobic residues shut the upper half of the pore (Fig. 4e, g). The upper constriction at 16′ results in a minimal diameter (dmin) of 2.3 Å. Interestingly, a phenylalanine (βF6′) orients into the pore, and with the L9′ ring together form the lower constriction point (dmin 1.7 Å) (Fig. 4g). In the desensitized state, the pore diameter at the 16′ gate widens from 2.3 to 6.5 Å, sufficient for hydration of the extracellular ~third of the pore (Fig. 4f). Movement of M2 helices away from the pore axis results in rotation or translation of L9’ side chains and βF6′, in a subunit-dependent manner (Fig. 4d), and an increase in diameter at the lower constriction (1.7 to 4.0 Å; Fig. 4f, g). This increased diameter is not expected to allow permeation of hydrated cations46. Accordingly, in the muscle receptor, the L9′ ring and βF6′ act in concert to form the desensitization gate while also contributing to the more extensive resting-state gate.
Figure 4: State transitions and gates in adult AChR.

a, Comparison of adult resting-like (light grey) and desensitized (colored) state structures reveals ECD conformational changes upon ACh binding. Toxin removed for clarity. b, c, Conformational changes in the coupling region (b) and the TMD regions (c) induced by ACh binding; colors as in a. d, Close-up top view of L9′ and F6′ orientations in different states; protein residues are shown as sticks; colors as in a. e, Permeation pathway in the resting-like state pore region; red dots indicate pore diameters less than 2.3 Å. f, As in e, but for the adult desensitized state; red dots here indicate pore diameters less than 4.1 Å. Pore lining residues in e and f are shown as sticks except βG2′, shown as a sphere. g, Pore profile of adult resting-like and desensitized structures. h, Comparison of whole cell patch clamp electrophysiology of adult wild type and mutants. i, Apparent desensitization rates (τ) of adult wild type (n = 5 independent cells, 0.40 ± 0.08 s), βF6′S (n = 6, 0.24 ± 0.02 s), βL9′S (n = 6, 1.84 ± 0.13 s), βF6′S/L9′S (n = 10, 0.87 ± 0.07 s) mutants. Welch’s analysis of variance (ANOVA) with Dunnett’s multiple comparisons test was used. Mean ± s.e.m.; boxes indicate the 25th to 75th percentiles, whiskers indicate the minimum and maximum values, and the central line shows the median; all data points are shown. j, Representative single-channel recordings from adult wild type and βF6′S mutant. O, open; C, closed.
The 6′ phenylalanine is strikingly rare among Cys-loop receptors, found only in mammalian muscle receptor β subunits and in the glycine receptor β subunit (Extended Data Fig. 9h, i)47,48. While the L9′ ring has been studied extensively49,50, βF6′ appears to have escaped notice; to see it occluding the permeation pathway in both the resting-like and desensitized states suggests it could provide a muscle receptor-specific control on permeation or gating. In macroscopic patch-clamp electrophysiology recordings, we found that the adult wild-type receptor desensitized rapidly, while the βF6′S mutation resulted in a slight increase in the apparent rate of desensitization (Fig. 4h, i). We were curious whether the strong L9′ gate masked effects from the βF6′S mutation, and thus tested single and double mutants including βL9′S. The βL9′S single mutant desensitized slowly and was more sensitive to ACh, consistent with previous reports49,50 (Extended Data Fig. 8a). Remarkably, the βF6′S+βL9′S double mutant largely restored the characteristically fast desensitization of the wild type receptor (Fig. 4h, i). In single channel analysis, we found that the βF6′S mutation results in briefer openings, a kinetic defect consistent with the macroscopic result (Fig. 4j, Extended Data Fig. 8b, c). These findings suggest that replacement of βF6′ with a polar residue, as found in nearly every other subunit, results in a fast-desensitizing channel. Our structural and functional data point to the L9′ ring being a major pore element controlling desensitization, with the βF6′ residue counteracting the stability of the desensitization gate. How might a bulky hydrophobic residue, found to occlude the pore in two non-conducting states, in fact enhance open channel duration? We suggest that the local environment of βF6′ is the key; all other subunits have a polar side chain at 6′, creating an unfavorable environment for the β subunit’s phenylalanine. An activated-state structure of the glycine receptor suggests that 6′F rotates out of the pore and into a hydrophobic pocket (Extended Data Fig. 9l, m)48. If the same occurs in the muscle AChR, we propose that βF6′ can impede conductance in resting and desensitized states through steric pore block, while also stabilizing the activated state by virtue of moving out of the pore and into a more favorable hydrophobic environment. This regulation is especially important in the muscle receptors that must respond to ACh with precise timing; openings that are either too brief or prolonged can be pathogenic, causing congenital myasthenic syndromes51.
Importantly, we found that the conformational transitions between fetal and adult muscle receptors were similar to each other (Extended Data Fig. 9a–g). Indeed, the resting-like and desensitized-state structures between fetal and adult have a root-mean-square deviation (RMSD) under 0.5 Å, suggesting high structural similarity (Extended Data Fig. 9j, k), consistent with desensitization not differing between these two isoforms21,52. Thus, although the fetal and adult muscle receptors are distinct in many channel properties, they appear to share a common gating mechanism.
Channel open duration
The fetal receptor has a longer open channel duration than the adult isoform3,11. This kinetic tuning allows fetal miniature end-plate currents (MEPCs) to trigger spontaneous contractions in the developing muscle fiber. Adult MEPCs do not cause contractions, as the AChR channels open too briefly7, but in contrast respond and then shut quickly during evoked transmission in the mature NMJ20. Comparison of the fetal and adult AChR structures suggests determinants of open time underlying development versus coordinated muscle contraction. We observed an electrostatic interaction network mediated by γT316 in the fetal receptor TMD, stabilizing the helical bundle (Fig. 5b). This network is disrupted by an alanine substitution (γT316 to εA315) in the adult AChR (Fig. 5c). We found that the γT316A mutant subtly decreases mean channel open time (Fig. 5d, Extended Data Fig. 8e, f), suggesting that multiple factors are required to explain the difference in channel open duration. Indeed, other residues, including γM482, regulate channel open time16. We find that γM482 inserts into a local hydrophobic pocket surrounded by several residues from M1, M3 and M4 (Fig. 5e). This interaction that stabilizes TMD helical packing is abolished by an alanine substitution in the adult (εA462) (Fig. 5f). Further, many congenital myasthenic syndromes (CMS) mutations, like εL289F and εV279F, increase TMD hydrophobic interactions, and have a longer open time (Extended Data Fig. 8j, k). These results suggest that stronger intrasubunit TMD interactions in the fetal vs. adult receptors act together in regulating channel open time.
Figure 5: Channel open time.

a, Structural comparison of fetal and adult TMD and ICD regions. b, c, Close-up views of different interactions in fetal and adult TMD regions. Interacting residues are shown as sticks. d, Representative single-channel recordings from fetal wild type, γT316A and γG461A mutants. O, open; C, closed. e, f, Close-up views of two key residues from the M4 helices and their interactions.
A 30-residue segment was found to tune the open durations of the two muscle receptor isoforms16. This segment corresponds to the MA helix, which forms the ICD portals and is continuous with M4 (Fig. 5a). The most striking difference between fetal and adult MA helices is in electrostatic potential (Extended Data Fig. 7k–m, q). However, a charge-reversal mutant did not change the channel open time (Fig. 3i). In activated-state structures of the α7 nicotinic and 5-HT3A receptors, the MA-M4 junction is suggested to unwind, to enlarge ICD portals for ion permeation and accommodate outward movement of TMD helices54,55 (Extended Data Fig. 7o, p). A glycine in the MA helix of the 5-HT3A receptor introduces greater flexibility at the MA-M4 junction to facilitate their disruption54. We observed more glycines in the MA-M4 junction in the fetal receptor compared to the adult (Extended Data Fig. 7q). Indeed, we found that glycine mutants, like γG461A, decrease the channel open time compared to wild type (Fig. 5d, Extended Data Fig. 8g, h). Together, we conclude that the difference in channel open duration between the fetal and adult receptors is governed by multiple factors, including the extensive intrasubunit interactions present in the fetal receptor that are absent in the adult isoform, and an increase MA structural flexibility.
ε subunit mutations cause congenital myasthenic syndromes
Mutations in the muscle AChR are the most common cause of CMS51. Approximately 80% of the mutations are found in the ε subunit26–28, and fall into two groups: those whose major effect is to alter channel kinetics; and those whose major effect is to reduce AChR expression. Here we leverage the structure of the ε-containing adult AChR to understand mechanisms of CMS pathogenesis (Fig. 6, Extended Data Fig. 8i–l). Among the kinetic mutants, fast-channel syndromes are typified by abnormally brief ion channel openings. Mutations concentrate in the ECD and ICD regions (Fig. 6a). εD195 is located on loop F and forms the only hydrogen bond across the interface with loop C (to αA211), pinning loop C shut around ACh (Fig. 6b). The εD195N mutation either abolishes or weakens this interaction, explaining the increased rate of ACh dissociation56,57. Slow-channel syndromes are typified by enhanced channel opening or delayed channel closing, resulting in longer-lived open states57. Slow-channel mutations cluster in the TMD, particularly in the pore-lining M2 helix (Fig. 6a). εV285A is the only pathogenic mutation on the εM2 helix wherein the side chain orients toward the channel axis to directly influence ion permeation. This 13′V position is conserved among the α, β, γ, δ and ε subunits, and forms part of the hydrophobic upper half of the pore and the strong barrier to hydration in the resting-like state (Fig. 6c). Pruning the side-chain to alanine would increase open probability by destabilizing the resting state; indeed, εV285A was found to increase the rate of channel opening by 6-fold58.
Figure 6: Structural context for congenital myasthenic syndromes.

a, CMS mutations mapped on adult ε subunit; blue, cyan, and yellow spheres indicate fast-, slow-channel, and receptor deficiency mutations respectively. For additional deficiency mutations also see Extended Data Figure 8j. b, Interaction between loops C and F in the desensitized state. ACh is shown as yellow sticks. c, εV285 at 13′ of εM2 forms a ring with four other valines to influence ion permeation. Gray arrow represents permeation pathway. d, The ε C-terminus forms a disulfide bond with the ECD. Corresponding residues in panel b, c, and d are shown as sticks. e, Sequence alignment indicates a conserved disulfide bond in the ε C-terminus among mammalian muscle receptors.
Many CMS patient mutations lead to primary receptor deficiency, a catch-all term for mutations that result in ~90% loss of AChRs on the motor endplate (Extended Data Fig. 8l)51. Among them, C490 is essential for cell surface expression and replacement of C490 by serine did not restore the receptor deficiency59. The pathogenic basis of this seemingly benign substitution has remained mysterious. Surprisingly, we found that this ε subunit C-terminal cysteine forms a disulfide bond with εC210, and would thereby stabilize the conformation of the C terminus and perhaps loop F as well (Fig. 6d). This disulfide bond interaction is conserved among mammalian muscle AChRs but absent in the preceding models of the Torpedo AChR (Fig. 6e). Together, mapping disease mutants on the muscle receptor structures provides new confidence in defining CMS pathological mechanisms.
Conclusions
Here we sought to determine the structure of the muscle AChR and how changes in it enable proper NMJ development. By isolating receptors from muscle tissue in a developmental transition, we were able to directly compare the structures of mammalian fetal and adult receptors. We found that a looser and more flexible ACh binding site in the adult receptor explains its adaptation to the high ACh concentrations at the synapse. We found that differences in electrostatic surfaces endow the two isoforms with different ion conductances geared toward their roles first in synapse formation and then in fast chemical neurotransmission. We further uncovered a pattern of extensive intrasubunit contacts specific to the fetal receptor that, when broken, result in shorter channel open times, like in the adult receptor. A surprise in the transmembrane pore revealed an extensive gate that includes a bulky hydrophobic residue tuning desensitization kinetics. These findings, integrated with decades of functional work on this prototypical receptor, and new electrophysiological tests, provide a detailed view of receptor changes in NMJ development and pathological mechanisms underlying CMS.
Methods
Preparation of the toxin affinity reagent
To extract receptor from tissue, we modified a consensus short chain neurotoxin60 to have two affinity tags, a polyhistidine tag for purifying the toxin itself from bacteria, and a FLAG tag to extract native receptors from muscle tissue. The pQE60-6his-3FLAG-ScNtx plasmid was transformed into K-12 derived SHuffle Express Competent B E. coli cells (NEB) for expression. The positive SHuffle cell colonies were first tested for toxin expression. For small scale screening of expression, the individual colonies were selected to grow in 5 mL of LB medium containing 100 μg/mL of ampicillin and 1 mM IPTG (isopropyl β-D-thiogalactoside; Sigma) at 37 °C overnight in a shaking incubator at 250 rpm. Cells were harvested and lysed using 30 μL plasmid extract lysis buffer. Expression was evaluated qualitatively by SDS-PAGE and Western blotting using anti-his-tag and anti-flag tag antibodies. The best expressing clone was used to perform large overexpression experiments.
For large scale expression and purification, an initial bacterial culture was grown overnight at 30 °C at 200 rpm in 5 mL LB plus ampicillin. Cells were diluted to 8 L in modified medium60 and grown at 37 °C to an OD600 of 1. Bacteria were then induced with 0.1 mM IPTG at 16 °C and 210 rpm for 20 h. Cells were next centrifuged at 5,000 × g, 20 min, 4 °C and the pellet was resuspended in protein lysis buffer (50 mM Tris-HCl pH 7.4, 500 mM NaCl, 15 mM imidazole and 1 mM PMSF (phenylmethylsulfonyl fluoride). The cell suspension was then passed four times through an Avestin C5 cell disruptor at 5,000-10,000 psi. The lysate supernatant was collected after centrifugation at 30,000 rpm, 4 °C for 30 min, and loaded onto a Ni–NTA affinity column, washed, and eluted. The peak fractions were concentrated and loaded onto a Superdex 75 Increase 10/300 GL column (Cytiva) for further purification. Purified toxins were stored at −80 °C.
ACh receptor preparation from bovine skeletal muscle tissue
One kg flash frozen fetal bovine skeletal muscle tissue at the 1st-2nd trimester (Animal Technologies) was weighed and then broken with a hammer into little smaller pieces. All further steps were performed at 4 °C except for the filtration step to remove fat (see below). The tissue was brought to ~4.2 L with buffered solution (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 10 mM EDTA, 10 mM imidazole, 10 mM iodoacetamide, 1 mM PMSF). The tissue was homogenized using a Ninja blender at the max speed for 2 min (coarse blending), then transferred into a Waring blender for 2 min at speed 5 (for fine blending). The insoluble material was then separated by centrifuging at 11,000 g for 2 h, resulting in a hard pellet, and the supernatant. The ~4.2 L supernatant was then centrifuged at 40,000 rpm for 1 h to precipitate the membrane pellet, the so-called soft pellet. Both the hard pellet and soft pellet contained ACh receptor protein based on the fluorescent-bungarotoxin FSEC assay; they were combined together for further extraction and purification.
M2 FLAG resin (Sigma, 2.5 mL) was washed using 200 mL cold TBS. The purified toxins were loaded onto the resin and recirculated at 4 °C for 5 h. Then, flow-through fractions were collected and the resin was washed using cold TBS again until no free toxin was detected in the flow-through fractions. The hard and soft pellets were resuspended in 2.2 L buffer containing 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF and cOmplete protease inhibitor cocktail (Sigma), and homogenized again for 30 s using the Waring blender. Next, Triton X-100 (Sigma) was added to a final concentration of 2.8%. After solubilization for 2 h nutating at 4 °C, the extract was centrifuged at 10,000 g for 1 h. The lipid layer and small fat drops were removed by passing through regularly exchanged filters (~30 exchanges per preparation, 185 mm Whatman filter papers, Cat No 1001-185) that were cut into circles and fitted into a bottle top vacuum filter holder. The clarified detergent extract was loaded onto the FLAG resin column pre-bound with toxin.
The ~2 L of extract was passed through the column using a peristaltic pump at 4 mL/min and 4 °C. To ensure sufficient binding, the flow through was recirculated through the resin for 40 h. After binding, the resin was washed with 200 mL washing buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM LMNG (Lauryl Maltose Neopentyl Glycol, Anatrace) and 10 μM soy polar lipids (Avanti Polar Lipids) plus cholesterol (Sigma) and DDM (n-dodecyl-β-D-maltoside, Anatrace) in a 4:1:1.84 w:w ratio). Wash fractions were analyzed by FSEC using intrinsic tryptophan signal to confirm that major contaminants were removed. ACh receptors bound to toxin were eluted using wash buffer supplemented to contain 200 μg/mL 3X FLAG peptide (Sigma), 0.25 mM LMNG and 10 μM soy lipids plus cholesterol. Samples were analyzed by FSEC using intrinsic tryptophan signal and fluorescently-labeled α-bungarotoxin (Thermo Scientific), pooled, and concentrated for preparative SEC (in 50 mM Tris pH 7.4, 150 mM NaCl, 0.25 mM LMNG, and 10 μM soy lipids plus cholesterol) using a Superose 6 Increase 10/300 GL column (Cytiva) and SDS-PAGE analysis. Peak SEC fractions were pooled and prepared for cryo-EM or alternately further treated to replace bound toxin with ACh, as described below.
Preparation of native receptors bound to ACh
We extended our toxin-based purification method to prepare the native receptors bound to acetylcholine. First, excess free toxin eluted with the receptor from flag resin was removed using a Superose 6 SEC column. The peak fractions containing the receptors were collected, pooled, and concentrated to 1 mL, and then this sample was diluted into 25 mL modified SEC buffer containing 1 M ACh, 0.25 mM LMNG, and 10 μM soy lipids plus cholesterol. The diluted sample was loaded onto a 1 mL FLAG resin column that was freshly washed with cold TBS. The sample was recirculated through the column for 3 days at a speed of 2 mL/min at 4 °C. After this binding step, the receptors that remained toxin-bound would re-bind to the FLAG resin, while the flow-through fractions should contain mainly ACh-bound receptors. The flow-through fractions were pooled, concentrated, and loaded onto a Superose 6 SEC column with a mobile phase containing 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.25 mM LMNG, 2 mM ACh and 10 μM soy lipids plus cholesterol, and the peak fractions were pooled and concentrated for further analysis and cryo-EM sample preparation.
Cryo-EM sample preparation
Three μL of purified proteins at a concentration of 0.2 mg/mL were added to a freshly glow discharged (30 mA, 10 s) 300-mesh copper grid covered with a 2 nm carbon film (R2/1, Quantifoil). Grids were immediately blotted for 3.5 s under 100% humidity at 4 °C with bolt force −15. Grids were plunge-frozen into liquid ethane using a Vitrobot. Grid quality was screened on the UCSD 200 kV Talos Arctica microscope. The grids with good ice, particle distribution, and particle density were saved.
Cryo-EM data collection and image processing
The toxin-bound sample EM data were comparatively straightforward to process. 8,050 dose-fractioned images were collected on the UCSD Titan Krios 2 at 300 kV with a total dose of 50 e−/Å2 and a magnification of 130,000x and 0.935 Å/pixel. The defocus range was set from −1.6 to −2.2 μm. All data processing was done using cryoSPARC v4.3 and 4.461. Dose-fractionated images were gain-normalized, motion corrected, and CTF estimation was done using default parameters in cryoSPARC. Particles were picked using the blob picker and extracted with a box size of 400 pixels and binned to 200 pixels. After several rounds of 2D classification, ~1.5 million particles were selected from classes with clear secondary structural features. Twenty thousand particles were randomly selected to generate a 3D model using ab initio reconstruction. All particles were then submitted into a 3D Homogeneous Refinement job, which revealed compositional heterogeneity at the γ/ε position. 3D classification was performed with 10 classes resulting in two good classes with stronger density and clear ICD and 8 classes with very weak ICD or/and TMD density. These two good classes exhibited very clear and distinctive features in their ECDs and M4 C-terminal extensions. These two good classes were re-extracted at full pixel size and subjected to Non-uniform (NU) Refinement62, optimizing per-particle defocus and per-exposure-group CTF parameters in each refinement iteration. NU refinement generated maps at a resolution of 2.09 Å for the adult receptor (209,258 particles) and 2.14 Å for the fetal receptor (168,720 particles), respectively. DeepEMhancer63 was used to improve the map quality before model building.
For the ACh-bound sample, ~30,000 images were collected using the settings as above except for a defocus range from −1.6 to −2.0 μm. All data processing was again performed using cryoSPARC v4.3 and 4.4, except for mask generation performed in Relion v4.064. After several rounds of 2D classification, ~3 million particles were kept and subjected to 3D Homogeneous Refinement using an initial model generated from randomly selected particles. The 3D reconstruction suggested that a small fraction of the particles contained bound toxin, and many particles had a damaged ICD (Extended Data Fig. 4). To first remove the toxin-bound particles, a soft mask focused on the ECD was generated using Relion_mask_creation based on the 3D homogeneous refinement map. The output particles from the initial refinement were then subjected to 3D classification (4 to 5 classes) using the ECD mask, then all particles without toxin bound were selected. To separate the fetal and adult receptor particles, a second smaller soft mask focused on the γ/ε ECD position was generated. The selected particles were further classified using this mask and all fetal and adult receptor particles were selected. To separate the complete particles from those without ICD density, a third soft mask focused on the TMD and ICD was generated. Both fetal and adult particles were classified using this focused mask; only one class for the fetal and one class for the adult receptor had strong and clear ICD density. To further improve the ICD region of γ and ε subunits, an additional 3D classification was performed for both fetal and adult particles. These classes were selected, re-extracted at full size and refined using cryoSPARC NU Refinement to a resolution of 2.45 Å for the adult receptor (167,900 particles) and 2.45 Å for the fetal receptor (259,740 particles).
Model building, refinement, and validation
Because of the high map resolution, we tested ModelAngelo65 in building models de novo into the toxin-bound fetal and adult ACh receptor maps. This auto building software generated two models that fit the maps well using supplied sequences, including the toxin, except in selected regions with worse local resolution. These two starting models, which included several fragments, were linked and checked manually residue by residue in Coot (version 0.9.8.93)66 along with global real space refinement in Phenix (version 1.20.1)67 with secondary structure and Ramachandran restraints. Model geometry and clash scores were checked using MolProbity68.
For the ACh-bound datasets, the refined toxin-bound structures were used as the starting models, and roughly fitted into the new density maps using UCSF Chimera (version 1.16)69. The pore and loop C regions, which exhibited larger conformational changes compared to the toxin-bound structures, fitted poorly and were manually rebuilt. ACh molecules were placed into unambiguous density in the classical neurotransmitter sites. We observed non-continuous, non-protein densities at the ECD-TMD junction in the channel vestibule, which were not present in the toxin-bound structures. These features were unmodeled due to ambiguity in composition. The initial models were refined against the two new ACh-containing maps in Phenix through several cycles of real space refinement. The improved models were then checked manually residue by residue in Coot along with global real space refinement in Phenix with secondary structure and Ramachandran restraints. Model geometry and clash scores were checked with MolProbity. Sequences for model building were downloaded from the UniProt database and sequence alignments were made using Clustal Omega70.
The pore diameter was calculated by HOLE 271. The map and structural figures were generated using UCSF Chimera, ChimeraX (version 1.7.1)72 and PyMOL (version 2.5.5, Schrodinger, LLC). The main text figures were made from density maps after post processing with DeepEMhancer. Density consistent with several cholesterol and phospholipids was present in each map, in positions also identified in a Torpedo receptor structure29. These densities were not very strong, but were built based on consistency with the earlier models.
Mass spectrometry analysis
Proteins were identified after SDS-PAGE separation using standard methods73 in the UCSD proteomics core. Protein bands near 50 kD were cut out from a gel stained with Coomassie blue using a clean blade. Gel slices were cut into 1 mm by 1 mm cubes and treated with 100 mM ammonium bicarbonate and acetonitrile to destain. The samples were then dried, reduced, alkylated, dehydrated, and subjected to trypsin digestion. After overnight digestion, peptides were extracted, and the combined extractions were analyzed using liquid chromatography and tandem mass spectrometry (LC-MS/MS) with electrospray ionization. The TimsTOF 2 pro mass spectrometer (Bruker) was utilized with a nano-scale reversed-phase UPLC system (EVOSEP ONE). The mass spectrometry settings included a PASEF method, with mobility-dependent collision energy ramping and target intensity per precursor. Peaks Studio X software was used for protein identification and label-free quantification.
Electrophysiology
Human α, β, δ, γ and ε gene sequences were downloaded from the UniProt database, synthesized by GenScript, and subcloned into the pEZT-BM vector74. Mutations were introduced by site directed mutagenesis. Whole cell and single channel voltage-clamp recordings were made from adherent HEK293S GnTI− cells transiently transfected with human α, β, δ, and either γ or ε (or their mutants) plasmids. Each 10 mm well of cells in a 12-well dish was transfected with 0.1–0.4 μg plasmid mixture of each subunit or their mutants in a ratio of 2α:1β:1δ:10γ/ε, using Lipofectamine 2000 reagent (Invitrogen). The transfected cells were incubated at 30 °C. After 48 h post-transfection, cells were re-plated on 35 mm dishes and allowed to settle for at least 3 hours. Recordings were made 48-96 h after transfection.
For whole cell voltage-clamp recording, the bath solution contained (in mM): 140 NaCl, 2.4 KCl, 4 MgCl2, 4 CaCl2, 5 HEPES and 10 glucose pH 7.3. Borosilicate pipettes were pulled and polished to an initial resistance of 2–4 MΩ, filled with the pipette solution containing (in mM): 100 CsCl, 30 CsF, 10 NaCl, 10 EGTA, and 20 HEPES pH 7.3. Whole cell currents were recorded with an Axopatch 200B amplifier, sampled at 20 kHz, and low-pass filtered at 2 kHz using a Digidata 1550B (Molecular Devices). Cells were held at −75 mV. Acetylcholine was prepared in bath solution from a 1 M concentrated stock stored at −80 °C and thawed twice per day. Solution exchange was achieved using a gravity driven RSC-200 rapid solution changer (Bio-Logic). Whole cell currents data were collected with pClamp 11 and analyzed with Clampfit 11 software (Molecular Devices). Desensitization curves were fitted with a single-phase exponential equation in Clampfit 11 software.
Single channel recordings were obtained in the cell-attached configuration. Bath solution contained (in mM) 140 KCl, 2.4 NaCl 4 MgCl2, 4 CaCl2, 5 HEPES and 10 glucose pH 7.3. Pipettes with a resistance ranging from 3–5 MΩ were filled with bath solution plus 10 μM acetylcholine. The single channel recording data were collected with an Axopatch 200B amplifier, sampled at 50 kHz, and low-pass filtered at 10 kHz using a Digidata 1550B (Molecular Devices). A command voltage ranging from 50 mV to 125 mV was applied to the interior of the patch pipette to establish the membrane potential. Detection of single channel open and closing, and the analysis of open duration times and single channel amplitude at a given commend voltage, were performed using TAC4.3.3 software (BruxtonCorp.).
Statistics and Reproducibility
For the whole-cell and single-channel electrophysiology experiments, statistical analysis was performed using GraphPad Prism 10.2.0 software (GraphPad software, Inc, La Jolla, CA). Data are expressed as mean ± s.e.m., the Welch’s t-test was used for Fig. 3j, and Welch’s analysis of variance (ANOVA) with Dunnett’s multiple comparisons test for Fig. 4i. In Fig. 4i, boxes indicate the 25th to 75th percentiles, whiskers indicate the minimum and maximum values, and the central line shows the median; all data points are shown. Replicate numbers n in each figure are the number of independent cells that the recordings are taken from.
Extended Data
Extended Data Figure 1: Isolation and identification of ACh receptors from bovine skeletal muscle.

a, Overview of methods for isolation of AChRs from one kg bovine muscle tissue. b, A method for preparation of ACh-bound receptors. c, Schematic of the fluorescently-labeled α-bungarotoxin detection assay. d, e, Identification of receptor from both hard pellet (d) and soft membrane pellet (e) using the fluorescently-labeled α-bungarotoxin detection assay. f, A final sample reveals strong tryptophan and α-bungarotoxin FSEC peaks. For d–f, chromatograms were obtained using a Sepax SRT SEC-500 column on a Shimadzu HPLC, flow rate of 0.35 mL/min. g, h, SDS-PAGE gels of purified bovine receptor bound with either short chain toxin (g) or ACh (h); for gel source data, see Supplementary Figure 1. This gel is representative of two gels run on independently purified receptors. i, Mass spectrometry identification of bovine receptor subunits.
Extended Data Figure 2: Cryo-EM data processing of toxin-bound receptors.

All steps were carried out in Cryosparc v4 (see Methods for details).
Extended Data Figure 3: Map quality enables subunit assignment.

a, b, Different map features of γ (a) and ε (b) subunits. Three types of structural features help to clearly distinguish the fetal and adult receptors and likely enabled facile classification of particles in cryo-EM data processing. First, glycosylation patterns are distinct. The γ subunit is glycosylated at Asn52 (γN52-glycan) located in the extracellular domain (ECD) β-sheet region (β5), while the ε is glycosylated at Asn86 (εN86-glycan) in a short loop adjacent to the N-terminus of the η2 helix on the apex of the ECD. Second, the C-termini of the γ and ε subunits differ in both length and conformation. The C-terminal extension in γ is larger and stabilized mainly by hydrophobic interactions with the ECD (c), while the C-terminus of the ε subunit is short, and stabilized by a disulfide bond (d). Third, there are amino acid differences in the initial N-terminal helix of each subunit, for example the fetal isoform has a glycine (γG31), and the adult has a histidine residue (εH29) at the corresponding position. To show glycosylation density clearly here, the threshold for the glycosylation map regions is lower than for the protein residues.
Extended Data Figure 4: Cryo-EM data processing of ACh-bound receptors.

All steps were carried out in Cryosparc v4 (see Methods for details).
Extended Data Figure 5: Cryo-EM FSC plots, local resolution, and angular distribution.

a–c, Masked FSC curve, local resolution, and angular distribution of particles for fetal ACh receptor + toxin. d–f, as a–c but for adult ACh receptor + toxin. g–I, As a–c but for fetal ACh receptor + ACh. j–l, As a–c but for adult ACh receptor + ACh.
Extended Data Figure 6: Structures of fetal and adult ACh receptors in different states.

a–d, Structures of fetal and adult receptors bound to either toxin or ACh; top and side views. e, αε interface labeled as an example to indicate domains, helices, glycans, and ACh binding pocket. f–j, ECD of each subunit to show the glycans. k–o, Different C-terminus from each subunit. p, Toxin densities in the αε and αδ interfaces. Density is shown for three residues on the tip of the toxin molecules inserting into the ACh binding pocket to illustrate confidence in interpreting interactions. q, r, Representative lipid densities in the TMD region. q, A phospholipid binds to the bottom of the TMD in the adult resting-like structure. The surrounding residues around the phospholipid are shown as sticks in the β-α interface. r, A phospholipid binds to the top of the TMD in the adult resting-like structure. The surrounding residues around the phospholipid are shown as sticks in the α-δ interface.
Extended Data Figure 7: Structural basis of ACh sensitivity and conductance.

a, b, Close-up views of fetal αγ (a) and adult αε (b) ACh binding pockets. Residues are shown as sticks and waters as cyan spheres. The αγ interface has two extra interactions, a disulfide bond and a hydrogen bond, compared to αε. c, d, Sequence alignments of the residues involved in these interactions. e, f, Accessible area and volume of ACh binding pocket in fetal and adult interfaces calculated using the program CASTp (http://sts.bioe.uic.edu/castp). The accessible volumes are shown as semi-transparent red chambers. g, h, Structures of fetal ECD (g) and ICD (h) show the non-negatively charged residues; γQ35, γN38, γT105, γY127 in ECD and γQ456, γT458, γS462, γG463 in ICD. i, j, Structures of adult ECD (i) and ICD (j) show the negatively charged residues at the corresponding positions of fetal receptor; εD33, εD36, εE103, εE125 in ECD and εD436, εE438, εE442, εE443 in ICD. k, l, Electrostatic potential of ICD outer surfaces of fetal (k) and adult (l) receptors reveal differences from MA helices; red, negative; blue, positive. m, n, ICD structures of fetal muscle receptor (m) and 5-HT3A receptor54 (n, PDB 6BE1) show that both have several positively charged resides in their MA helices; in the fetal receptor, γR452, γR454, γH459, and γK465 have been replaced by εS432, εT434, εA439, and εS445 in adult. o, p, Single subunit structure of the α7 nicotinic ACh receptor (o) and 5-HT3A receptor54,75 (p) in both resting and activated states show that the M4-MA junctions are disrupted during channel opening. q, Sequence alignments of MA helices of bovine and human muscle isoforms reveal differently charged residues; negative, red; positive, blue.
Extended Data Figure 8: Electrophysiology analysis of gating residues and congenital myasthenic syndrome sites in the ε subunit.

a, Representative whole cell patch-clamp electrophysiology recordings from the adult wild type AChR and mutants. b, c, Representative single channel cluster duration histograms fitted by a sum of exponentials for adult wild type (b) and βF6′S mutant (c) AChRs; fitted curves for each component (dashed lines) and their sum (bold lines, the peak is indicated by a black line) are displayed; n ≥ 5 cells for each recording. d, Representative single channel recordings from βL9′S and βF6′S/L9′S mutants. e–h, As in b, c, but for fetal wild type (e, n = 3), γT316A mutant (f, n = 3), γG461E mutant (g, n = 4) and γG461A mutant (h, n = 3). The γT316A mutant subtly shortens the longer duration component of opening and the γG461E mutant slightly reduces the frequency of the longer duration component of opening while the γG461A mutant decreases the channel open time. i, Coupling region of ε subunit showing a site of two mutations causing fast channel CMS in patients. εE204 and εR238 form an electrostatic interaction network with εE65 on the β1β2-loop and εD158 on the Cys-loop, which couple ACh binding to channel opening. Both εE204K and εR238W mutations would destabilize this network and thereby diminish coupling efficiency, which would slow the rate of channel opening, leading to fast-channel syndrome76. j, k, Slow channel mutant examples at the TMD interface (top view) of α and ε subunits. εL289 (j) and εV279 (k) on M2 nestle into a pocket formed by several hydrophobic residues at the α-ε TMD interface. εL289F and εV279F mutations would result in clashes with nearby residues in the observed resting-like conformation, which could thereby destabilize the resting state in favor of a longer-lived activated state, consistent with the slow-channel CMS phenotype77,78. l, Examples of point mutants that cause receptor deficiency CMS51, shown as yellow spheres.
Extended Data Figure 9: State transition and gates in fetal AChR.

a, Comparison of fetal resting-like (light grey) and desensitized (colored) state structures reveals ECD conformational changes upon ACh binding. b, c, Conformational changes in the coupling region (b) and the TMD regions (c) triggered by ACh binding; colors as in a. d, Close-up top view of L9′ and F6′ changes in different fetal receptor states; colors as in a. e, Permeation pathway in the resting-like state pore region; red dots indicate pore diameters less than 2.2 Å. f, As in e, but for the fetal desensitized state; red dots here indicate < 4.1 Å. g, Pore profiles of fetal resting-like and desensitized structures. h, i, Sequence alignments of 6′ and 9′ at M2 helices among Cys-loop family receptors; h, among different species; i, in humans. j, k, Structural comparisons of fetal and adult receptors at different state reveal high similarity. l, m, Structures and conformations of the 6′ and 9′ residues in M2 helices in the apo (l) and open (m) heteromeric glycine receptors48.
Extended Data Video 1: Cryo-EM map-model agreement in the adult receptor.
Maps shown are those generated through DeepEMhancer postprocessing, except for the pore region in the ACh-bound adult receptor, where the unsharpened map is displayed.
Extended Data Video 2: Adult receptor state transitions.
In both α subunits, ACh binding coincides with loop C clamping down ~9 Å toward the channel axis, forming an aromatic box around the agonist (Fig. 4a). Loop F from the complementary subunits (ε and δ) moves up and toward the closed loop C, positioned to form an H-bond between the loop C backbone and an aspartic acid conserved in all complementary subunits (Fig. 4a). These local conformational changes coincide with twisting of the α subunit ECDs, approximately as rigid bodies, such that upon ACh binding, the Cys-loop and β1β2 loops move toward the channel axis. This movement in the ECD component of the coupling region results in the α subunit M2-M3 loops swinging outward, pulling the extracellular ends of α-M2 away from the channel axis (Fig. 4b). The coupling region transitions in the ε and δ subunits are similar to each other but distinct from the α subunits in that the whole intra-subunit coupling region largely behaves as a rigid body. Here, β1β2-loop interactions with the M2-M3 loop remain intact and both pivot outward and away from the channel axis (Fig. 4b, c, Extended Data Video 2). The conformational transition of the β subunit is the subtlest; as seen in the Torpedo receptor29, this subunit appears to act like a semi-rigid scaffold.
Extended Data Table 1.
Cryo-EM data collection, refinement and validation statistics
| Fetal receptor + neurotoxin (EMD-43926) (PDB 9AWK) |
Adult receptor + neurotoxin (EMD-43924) (PDB 9AVV) |
Fetal receptor + ACh (EMD-43923) (PDB 9AVU) |
Adult receptor + ACh (EMD-43925) (PDB 9AWJ) |
|
|---|---|---|---|---|
| Data collection and processing | ||||
| Magnification | 130,000× | 130,000× | ||
| Voltage (kV) | 300 | 300 | ||
| Electron exposure (e−/Å2) | 50 | 50 | ||
| Defocus range (μm) | −1.6 to −2.2 | −1.6 to −2.0 | ||
| Pixel size (Å) | 0.935 | 0.935 | ||
| Symmetry imposed | C1 | C1 | ||
| Initial particle images (no.) | ~1.5 million | ~3 million | ||
| Final particle images (no.) | 168,720 | 209,258 | 259,740 | 167,900 |
| Map resolution (Å) | 2.14 | 2.09 | 2.45 | 2.45 |
| FSC threshold | 0.143 | 0.143 | 0.143 | 0.143 |
| Refinement | ||||
| Initial model used (PDB code) | N/A | N/A | 9AWK | 9AVV |
| Model resolution (Å) | 2.42 | 2.31 | 2.63 | 2.67 |
| FSC threshold | 0.5 | 0.5 | 0.5 | 0.5 |
| Map sharpening B factor (Å2) | −14.5 | −40.1 | −40.1 | −29.7 |
| Model-to-map, CCmask | 0.82 | 0.80 | 0.80 | 0.82 |
| Model composition | ||||
| Non-hydrogen atoms | 18,111 | 18,176 | 17,065 | 17,003 |
| Protein residues | 2,167 | 2,176 | 2,047 | 2,041 |
| Ligands | 45 | 45 | 42 | 43 |
| Water | 0 | 0 | 5 | 5 |
| B factors (Å2) | ||||
| Protein | 61.10 | 39.13 | 80.05 | 75.02 |
| Ligand | 63.04 | 40.97 | 75.66 | 73.44 |
| Water | - | - | 49.11 | 48.60 |
| R.m.s. deviations | ||||
| Bond lengths (Å) | 0.006 | 0.006 | 0.005 | 0.005 |
| Bond angles (°) | 0.882 | 0.947 | 0.817 | 0.805 |
| Validation | ||||
| MolProbity score | 1.14 | 1.15 | 1.14 | 1.13 |
| Clashscore | 3.50 | 3.57 | 2.90 | 3.09 |
| Poor rotamers (%) | 0.30 | 0.60 | 0.32 | 0.43 |
| Ramachandran plot | ||||
| Favored (%) | 97.99 | 98.09 | 97.73 | 97.87 |
| Allowed (%) | 2.01 | 1.91 | 2.27 | 2.13 |
| Disallowed (%) | 0.00 | 0.00 | 0.00 | 0.00 |
Supplementary Material
Acknowledgements
We thank C. Noviello for project discussions, S. Burke, L. Baxter, H. Jiang, and S. Sine for critical feedback on the manuscript, and all Hibbs lab members for support. We also thank the UC San Diego Cryo-EM Facility and its staff members, M. Matyszewski and I. Kuschnerus, for their scientific and technical assistance, M. Ghassemian for mass spectrometry support, and C. daCosta for guidance in single channel software. This work was supported by grants from the Myasthenia Gravis Foundation of America and the NIH (NS120496) to REH.
Footnotes
Competing interests
The authors declare no competing interests.
Additional information
Supplementary Information is available for this paper.
Data availability
All atomic models and cryo-EM maps have been deposited in the Protein Data Bank and Electron Microscopy Data Bank: fetal resting-like (PDB 9AWK, EMD-43926); adult resting-like (PDB 9AVV, EMD-43924); fetal ACh-bound (PDB 9AVU, EMD-43923); and adult ACh-bound (PDB 9AWJ, EMD-43925). All other data are available upon request.
References
- 1.Sanes JR & Lichtman JW DEVELOPMENT OF THE VERTEBRATE NEUROMUSCULAR JUNCTION. Annual Review of Neuroscience 22, 389–442 (1999). 10.1146/annurev.neuro.22.1.389 [DOI] [PubMed] [Google Scholar]
- 2.Missias AC, Chu GC, Klocke BJ, Sanes JR & Merlie JP Maturation of the Acetylcholine Receptor in Skeletal Muscle: Regulation of the AChR γ-to-ϵ Switch. Developmental Biology 179, 223–238 (1996). 10.1006/dbio.1996.0253 [DOI] [PubMed] [Google Scholar]
- 3.Mishina M et al. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature 321, 406–411 (1986). 10.1038/321406a0 [DOI] [PubMed] [Google Scholar]
- 4.Sakmann B & Brenner HR Change in synaptic channel gating during neuromuscular development. Nature 276, 401–402 (1978). 10.1038/276401a0 [DOI] [PubMed] [Google Scholar]
- 5.Hesselmans LFGM, Jennekens FGI, Van Den Oord CJM, Veldman H & Vincent A Development of innervation of skeletal muscle fibers in man: Relation to acetylcholine receptors. The Anatomical Record 236, 553–562 (1993). 10.1002/ar.1092360315 [DOI] [PubMed] [Google Scholar]
- 6.Liu Y et al. Essential roles of the acetylcholine receptor γ-subunit in neuromuscular synaptic patterning. Development 135, 1957–1967 (2008). 10.1242/dev.018119 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Jaramillo F, Vicini S & Schuetze SM Embryonic acetylcholine receptors guarantee spontaneous contractions in rat developing muscle. Nature 335, 66–68 (1988). 10.1038/335066a0 [DOI] [PubMed] [Google Scholar]
- 8.Kidokoro Y & Saito M Early cross-striation formation in twitching Xenopus myocytes in culture. Proceedings of the National Academy of Sciences 85, 1978–1982 (1988). 10.1073/pnas.85.6.1978 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Zhang BGX et al. Combination of agrin and laminin increase acetylcholine receptor clustering and enhance functional neuromuscular junction formation In vitro. Developmental Neurobiology 76, 551–565 (2016). 10.1002/dneu.22331 [DOI] [PubMed] [Google Scholar]
- 10.Madhavan R & Peng HB A synaptic balancing act: Local and global signaling in the clustering of ACh receptors at vertebrate neuromuscular junctions. Journal of Neurocytology 32, 685–696 (2003). 10.1023/B:NEUR.0000020617.05656.68 [DOI] [PubMed] [Google Scholar]
- 11.Cetin H, Beeson D, Vincent A & Webster R The Structure, Function, and Physiology of the Fetal and Adult Acetylcholine Receptor in Muscle. Frontiers in Molecular Neuroscience 13 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Rimer M, Mathiesen I, Lømo T & McMahan UJ γ-AChR/ϵ-AChR Switch at Agrin-Induced Postsynaptic-like Apparatus in Skeletal Muscle. Molecular and Cellular Neuroscience 9, 254–263 (1997). 10.1006/mcne.1997.0622 [DOI] [PubMed] [Google Scholar]
- 13.Nayak TK, Chakraborty S, Zheng W & Auerbach A Structural correlates of affinity in fetal versus adult endplate nicotinic receptors. Nature Communications 7, 11352 (2016). 10.1038/ncomms11352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Nayak TK et al. Functional differences between neurotransmitter binding sites of muscle acetylcholine receptors. Proceedings of the National Academy of Sciences 111, 17660–17665 (2014). 10.1073/pnas.1414378111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Nayak TK & Auerbach A Asymmetric transmitter binding sites of fetal muscle acetylcholine receptors shape their synaptic response. Proceedings of the National Academy of Sciences 110, 13654–13659 (2013). 10.1073/pnas.1308247110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bouzat C, Bren N & Sine SM Structural basis of the different gating kinetics of fetal and adult acetylcholine receptors. Neuron 13, 1395–1402 (1994). 10.1016/0896-6273(94)90424-3 [DOI] [PubMed] [Google Scholar]
- 17.Herlitze S, Villarroel A, Witzemann V, Koenen M & Sakmann B Structural determinants of channel conductance in fetal and adult rat muscle acetylcholine receptors. The Journal of Physiology 492, 775–787 (1996). 10.1113/jphysiol.1996.sp021345 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Rubin LL, Schuetze SM, Weill CL & Fischbach GD Regulation of acetylcholinesterase appearance at neuromuscular junctions in vitro. Nature 283, 264–267 (1980). 10.1038/283264a0 [DOI] [PubMed] [Google Scholar]
- 19.Lomo T, Massoulie J & Vigny M Stimulation of denervated rat soleus muscle with fast and slow activity patterns induces different expression of acetylcholinesterase molecular forms. The Journal of Neuroscience 5, 1180 (1985). 10.1523/JNEUROSCI.05-05-01180.1985 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Takahashi M et al. Spontaneous muscle action potentials fail to develop without fetal-type acetylcholine receptors. EMBO reports 3, 674–681-681 (2002). 10.1093/embo-reports/kvf128 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cetin H et al. Rapsyn facilitates recovery from desensitization in fetal and adult acetylcholine receptors expressed in a muscle cell line. The Journal of Physiology 597, 3713–3725 (2019). 10.1113/JP277819 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Matthews-Bellinger J & Salpeter MM Distribution of acetylcholine receptors at frog neuromuscular junctions with a discussion of some physiological implications. The Journal of Physiology 279, 197–213 (1978). 10.1113/jphysiol.1978.sp012340 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Unwin N Acetylcholine receptor channel imaged in the open state. Nature 373, 37–43 (1995). 10.1038/373037a0 [DOI] [PubMed] [Google Scholar]
- 24.Rahman MM et al. Structure of the Native Muscle-type Nicotinic Receptor and Inhibition by Snake Venom Toxins. Neuron 106, 952–962.e955 (2020). 10.1016/j.neuron.2020.03.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Takai T et al. Cloning, sequencing and expression of cDNA for a novel subunit of acetylcholine receptor from calf muscle. Nature 315, 761–764 (1985). 10.1038/315761a0 [DOI] [PubMed] [Google Scholar]
- 26.Yang K et al. CHRNE compound heterozygous mutations in congenital myasthenic syndrome: A case report. Medicine 97 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Rodríguez Cruz PM, Palace J & Beeson D The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes. International Journal of Molecular Sciences 19 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Gilhus NE in Handbook of Clinical Neurology Vol. 195 (ed Younger David S) 635–652 (Elsevier, 2023). [DOI] [PubMed] [Google Scholar]
- 29.Rahman MM et al. Structural mechanism of muscle nicotinic receptor desensitization and block by curare. Nature Structural & Molecular Biology 29, 386–394 (2022). 10.1038/s41594-022-00737-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Zarkadas E et al. Conformational transitions and ligand-binding to a muscle-type nicotinic acetylcholine receptor. Neuron 110, 1358–1370.e1355 (2022). 10.1016/j.neuron.2022.01.013 [DOI] [PubMed] [Google Scholar]
- 31.Lindstrom JM & Lambert EH Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome. Neurology 28, 130–130 (1978). 10.1212/WNL.28.2.130 [DOI] [PubMed] [Google Scholar]
- 32.Einarson B, Gullick W, Conti-Tronconi B, Ellisman M & Lindstrom J Subunit composition of bovine muscle acetylcholine receptor. Biochemistry 21, 5295–5302 (1982). 10.1021/bi00264a027 [DOI] [PubMed] [Google Scholar]
- 33.Nys M et al. The molecular mechanism of snake short-chain α-neurotoxin binding to muscle-type nicotinic acetylcholine receptors. Nature Communications 13, 4543 (2022). 10.1038/s41467-022-32174-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Moore MA & McCarthy MP Snake venom toxins, unlike smaller antagonists, appear to stabilize a resting state conformation of the nicotinic acetylcholine receptor. Biochimica et Biophysica Acta (BBA) - Biomembranes 1235, 336–342 (1995). 10.1016/0005-2736(95)80022-8 [DOI] [PubMed] [Google Scholar]
- 35.Polak RL, Sellin LC & Thesleff S Acetylcholine content and release in denervated or botulinum poisoned rat skeletal muscle. The Journal of Physiology 319, 253–259 (1981). 10.1113/jphysiol.1981.sp013905 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Rich MM & Pinter MJ Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Annals of Neurology 50, 26–33 (2001). 10.1002/ana.1016 [DOI] [PubMed] [Google Scholar]
- 37.Fucile S, Sucapane A, Grassi F, Eusebi F & Engel AG The human adult subtype ACh receptor channel has high Ca2+ permeability and predisposes to endplate Ca2+ overloading. The Journal of Physiology 573, 35–43 (2006). 10.1113/jphysiol.2006.108092 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Ragozzino D, Barabino B, Fucile S & Eusebi F Ca2+ permeability of mouse and chick nicotinic acetylcholine receptors expressed in transiently transfected human cells. The Journal of Physiology 507, 749–758 (1998). 10.1111/j.1469-7793.1998.749bs.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Imoto K et al. Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance. Nature 335, 645–648 (1988). 10.1038/335645a0 [DOI] [PubMed] [Google Scholar]
- 40.Unwin N Refined Structure of the Nicotinic Acetylcholine Receptor at 4Å Resolution. Journal of Molecular Biology 346, 967–989 (2005). 10.1016/j.jmb.2004.12.031 [DOI] [PubMed] [Google Scholar]
- 41.Hansen SB, Wang H-L, Taylor P & Sine SM An Ion Selectivity Filter in the Extracellular Domain of Cys-loop Receptors Reveals Determinants for Ion Conductance*. Journal of Biological Chemistry 283, 36066–36070 (2008). 10.1074/jbc.C800194200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Gharpure A et al. Agonist Selectivity and Ion Permeation in the α3β4 Ganglionic Nicotinic Receptor. Neuron 104, 501–511.e506 (2019). 10.1016/j.neuron.2019.07.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Hussy N, Lukas W & Jones KA Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors. The Journal of Physiology 481, 311–323 (1994). 10.1113/jphysiol.1994.sp020441 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Walsh RM et al. Structural principles of distinct assemblies of the human α4β2 nicotinic receptor. Nature 557, 261–265 (2018). 10.1038/s41586-018-0081-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Tapia L, Kuryatov A & Lindstrom J Ca2+ permeability of the (alpha4)3(beta2)2 stoichiometry greatly exceeds that of (alpha4)2(beta2)3 human acetylcholine receptors. Mol Pharmacol 71, 769–776 (2007). 10.1124/mol.106.030445 [DOI] [PubMed] [Google Scholar]
- 46.Dwyer TM, Adams DJ & Hille B The permeability of the endplate channel to organic cations in frog muscle. Journal of General Physiology 75, 469–492 (1980). 10.1085/jgp.75.5.469 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zhu H & Gouaux E Architecture and assembly mechanism of native glycine receptors. Nature 599, 513–517 (2021). 10.1038/s41586-021-04022-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Liu X & Wang W Asymmetric gating of a human hetero-pentameric glycine receptor. Nature Communications 14, 6377 (2023). 10.1038/s41467-023-42051-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Labarca C et al. Channel gating governed symmetrically by conserved leucine residues in the M2 domain of nicotinic receptors. Nature 376, 514–516 (1995). 10.1038/376514a0 [DOI] [PubMed] [Google Scholar]
- 50.Filatov GN & White MM The role of conserved leucines in the M2 domain of the acetylcholine receptor in channel gating. Mol Pharmacol 48, 379 (1995). [PubMed] [Google Scholar]
- 51.Engel AG, Shen X-M, Selcen D & Sine SM Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. The Lancet Neurology 14, 420–434 (2015). 10.1016/S1474-4422(14)70201-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Jahn K et al. Deactivation and desensitization of mouse embryonic- and adult-type nicotinic receptor channel currents. Neuroscience Letters 307, 89–92 (2001). 10.1016/S0304-3940(01)01929-2 [DOI] [PubMed] [Google Scholar]
- 53.Barrantes FJ Structural basis for lipid modulation of nicotinic acetylcholine receptor function. Brain Research Reviews 47, 71–95 (2004). 10.1016/j.brainresrev.2004.06.008 [DOI] [PubMed] [Google Scholar]
- 54.Basak S, Gicheru Y, Rao S, Sansom MSP & Chakrapani S Cryo-EM reveals two distinct serotonin-bound conformations of full-length 5-HT3A receptor. Nature 563, 270–274 (2018). 10.1038/s41586-018-0660-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Noviello CM et al. Structure and gating mechanism of the α7 nicotinic acetylcholine receptor. Cell 184, 2121–2134.e2113 (2021). 10.1016/j.cell.2021.02.049 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Sine SM et al. Naturally Occurring Mutations at the Acetylcholine Receptor Binding Site Independently Alter ACh Binding and Channel Gating. Journal of General Physiology 120, 483–496 (2002). 10.1085/jgp.20028568 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Sine SM et al. Mechanistic Diversity Underlying Fast Channel Congenital Myasthenic Syndromes. Annals of the New York Academy of Sciences 998, 128–137 (2003). 10.1196/annals.1254.015 [DOI] [PubMed] [Google Scholar]
- 58.Shen X-M et al. Mutations Causing Slow-Channel Myasthenia Reveal That a Valine Ring in the Channel Pore of Muscle AChR is Optimized for Stabilizing Channel Gating. Human Mutation 37, 1051–1059 (2016). 10.1002/humu.23043 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Ealing J et al. Mutations in congenital myasthenic syndromes reveal an ε subunit C-terminal cysteine, C470, crucial for maturation and surface expression of adult AChR. Human Molecular Genetics 11, 3087–3096 (2002). 10.1093/hmg/11.24.3087 [DOI] [PubMed] [Google Scholar]
Methods references
- 60.de la Rosa G, Corrales-García LL, Rodriguez-Ruiz X, López-Vera E & Corzo G Short-chain consensus alpha-neurotoxin: a synthetic 60-mer peptide with generic traits and enhanced immunogenic properties. Amino Acids 50, 885–895 (2018). 10.1007/s00726-018-2556-0 [DOI] [PubMed] [Google Scholar]
- 61.Punjani A, Rubinstein JL, Fleet DJ & Brubaker MA cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nature Methods 14, 290–296 (2017). 10.1038/nmeth.4169 [DOI] [PubMed] [Google Scholar]
- 62.Punjani A, Zhang H & Fleet DJ Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nature Methods 17, 1214–1221 (2020). 10.1038/s41592-020-00990-8 [DOI] [PubMed] [Google Scholar]
- 63.Sanchez-Garcia R et al. DeepEMhancer: a deep learning solution for cryo-EM volume post-processing. Communications Biology 4, 874 (2021). 10.1038/s42003-021-02399-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Kimanius D, Dong L, Sharov G, Nakane T & Scheres SHW New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochemical Journal 478, 4169–4185 (2021). 10.1042/BCJ20210708 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Jamali K et al. Automated model building and protein identification in cryo-EM maps. Nature (2024). 10.1038/s41586-024-07215-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Emsley P & Cowtan K Coot: model-building tools for molecular graphics. Acta Crystallographica Section D 60, 2126–2132 (2004). 10.1107/S0907444904019158 [DOI] [PubMed] [Google Scholar]
- 67.Adams PD et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallographica Section D 66, 213–221 (2010). 10.1107/S0907444909052925 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Chen VB et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallographica Section D 66, 12–21 (2010). 10.1107/S0907444909042073 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Pettersen EF et al. UCSF Chimera—A visualization system for exploratory research and analysis. Journal of Computational Chemistry 25, 1605–1612 (2004). 10.1002/jcc.20084 [DOI] [PubMed] [Google Scholar]
- 70.Sievers F & Higgins DG Clustal Omega. Current Protocols in Bioinformatics 48, 3.13.11–13.13.16 (2014). 10.1002/0471250953.bi0313s48 [DOI] [PubMed] [Google Scholar]
- 71.Smart OS, Neduvelil JG, Wang X, Wallace BA & Sansom MSP HOLE: A program for the analysis of the pore dimensions of ion channel structural models. Journal of Molecular Graphics 14, 354–360 (1996). 10.1016/S0263-7855(97)00009-X [DOI] [PubMed] [Google Scholar]
- 72.Pettersen EF et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Science 30, 70–82 (2021). 10.1002/pro.3943 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Shevchenko A, Wilm M, Vorm O & Mann M Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels. Analytical Chemistry 68, 850–858 (1996). 10.1021/ac950914h [DOI] [PubMed] [Google Scholar]
- 74.Morales-Perez Claudio L, Noviello Colleen M. & Hibbs Ryan E. Manipulation of Subunit Stoichiometry in Heteromeric Membrane Proteins. Structure 24, 797–805 (2016). 10.1016/j.str.2016.03.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Basak S et al. Cryo-EM structure of 5-HT3A receptor in its resting conformation. Nature Communications 9, 514 (2018). 10.1038/s41467-018-02997-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Shen X-M et al. Mutations causing congenital myasthenia reveal principal coupling pathway in the acetylcholine receptor ε-subunit. JCI Insight 3 (2018). 10.1172/jci.insight.97826 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Engel AG et al. New Mutations in Acetylcholine Receptor Subunit Genes Reveal Heterogeneity in the Slow-Channel Congenital Myasthenic Syndrome. Human Molecular Genetics 5, 1217–1227 (1996). 10.1093/hmg/5.9.1217 [DOI] [PubMed] [Google Scholar]
- 78.Fidzianska A, Ryniewicz B, Shen X-M & Engel AG IBM-type inclusions in a patient with slow-channel syndrome caused by a mutation in the AChR epsilon subunit. Neuromuscular Disorders 15, 753–759 (2005). 10.1016/j.nmd.2005.07.009 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All atomic models and cryo-EM maps have been deposited in the Protein Data Bank and Electron Microscopy Data Bank: fetal resting-like (PDB 9AWK, EMD-43926); adult resting-like (PDB 9AVV, EMD-43924); fetal ACh-bound (PDB 9AVU, EMD-43923); and adult ACh-bound (PDB 9AWJ, EMD-43925). All other data are available upon request.
